Interestingly, the present study provides in vitro evidence that SEMA4D is involved in tumour progression and metastasis in CRC, and that its inhibition prevents the invasion and migration of HCT116 cells, which corresponds to the findings of previous reports. Here, SEMA4D is linked to colorectal carcinoma.